10 studies found for: "membranoproliferative glomerulonephritis type II" OR "Glomerulonephritis, Membranoproliferative"
Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
Sulodexide Treatment in Patients With Dense Deposit Disease
|5||Active, not recruiting||
Eculizumab in Primary MPGN
TP10 Use in Patients With C3 Glomerulopathy (C3G)
|7||Not yet recruiting||
Daratumumab in Treatment of PGNIMD and C3 GN
|8||Not yet recruiting||
A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN
BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis
Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
† Study has passed its completion date and status has not been verified in more than two years.